Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | homosalate | 5585 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | homosalate | 5585 | drug-path |
| Shigellosis | 0 | map05131 | homosalate | 5585 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | homosalate | 5585 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | homosalate | 5585 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | mebhydrolin | 22530 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | mebhydrolin | 22530 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | mebhydrolin | 22530 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | mebhydrolin | 22530 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | mebhydrolin | 22530 | drug-path |
| Asthma | R-HSA-444620 | map05310 | mebhydrolin | 22530 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | mebhydrolin | 22530 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | mebhydrolin | 22530 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | mebhydrolin | 22530 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | mebhydrolin | 22530 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | mebhydrolin | 22530 | drug-path |
| Vibrio cholerae infection | R-HSA-9609646 | map05110 | mebhydrolin | 22530 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | mebhydrolin | 22530 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | santonin | 3055 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | santonin | 3055 | drug-path |